JACLYN WOZNIUK: Open Payments
NPI 1710381249 · MT PLEASANT, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$245 in 13 payments from 7 companies in 2025. Trend: 2023 $1,301 · 2024 $1,339 · 2025 $245
Food & beverage: $245
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 4 | $77 |
| Astellas Pharma US Inc | 3 | $61 |
| PFIZER INC. | 2 | $34 |
| Novo Nordisk Inc | 1 | $23 |
| Axsome Therapeutics, Inc. | 1 | $19 |
| GlaxoSmithKline, LLC. | 1 | $16 |
| Daiichi Sankyo Inc. | 1 | $15 |
Products named: Veozah, LEQVIO, ELIQUIS, Ozempic, Auvelity, ENTRESTO, SHINGRIX, INJECTAFER.
Industry payments across SC — which companies pay providers there.
